Type
. M. leprae genome sequence. Trends in microbiology. 2001;9(4):157.
Type
. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends in immunology. 2001;22(3):130-6.
Type
. Corneal blindness: a global perspective. Bulletin of the World Health Organization [Internet]. 2001;79(3):214-21. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566379/pdf/11285665.pdf
Type
. Hansen's disease in a native-born, United States resident, after a brief stay in an endemic area abroad. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2001;5(1):49-52.
Type
. Index of suspicion. Case 2. Diagnosis: Leprosy. Pediatrics in review. 2001;22(1):22-31.
Type
. Tumor necrosis factor-alpha promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients. Immunogenetics. 2001;53(1):45-7.
Type
. Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples. Drug metabolism and disposition: the biological fate of chemicals. 2001;29(4 Pt 2):479-83.
Type
. Eradication of leprosy. Journal of the Indian Medical Association. 2000;98(10):646.
Type
. CD1 proteins: targets of T cell recognition in innate and adaptive immunity. Reviews in immunogenetics. 2000;2(3):416-32.
Type
. Update on leprosy in immigrants in the United States: status in the year 2000. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2001;32(6):930-7.